Praxbind, Pradaxa reversal agent, FDA approval, emergency situations
Technology | Antiplatelet and Anticoagulation Therapies | October 19, 2015
October 19, 2015 — The U.S. Food and Drug Administration (FDA) granted accelerated approval to Praxbind (idarucizumab)...
Amaranth Fortitute Bioresorbable stent

The Amaranth Fortitute bioresorbable stent was among several fully bioresorbing platforms discussed in sessions, late breaking trial data presentations and on the expo floor at TCT 2015.

Feature | TCT | October 19, 2015 | Tom Watson, BS, RCVT, Clinical Analyst, MD Buyline
There were several overarching technology trends seen at the 2015 Transcatheter Cardiovascular Therapeutics (TCT)...
transradial access, TRI, DRAGON trial, TCT 2015, non-inferiority, transfemoral access, TFO
Feature | Radial Access | October 18, 2015
October 18, 2015 — Results from a prospective randomized trial of...
FFR-CT, cost and quality of life outcomes, TCT 2015, PLATFORM trial

Image courtesy of HeartFlow Inc.

Feature | CT Angiography (CTA) | October 18, 2015
October 18, 2015 — New results from a multicenter, prospective study show that assessing...
IN.PACT SFA study, TCT 2015, drug-coated balloons, PTA, SFA disease, superficial femoral artery

Image courtesy of Medtronic

Feature | Peripheral Arterial Disease (PAD) | October 18, 2015
October 18, 2015 — Two-year results from the IN.PACT SFA study found the use of a...
cardiac MRI, heart age, left ventricular change, Multi-Ethnic Study of Atherosclerosis
News | Cardiac Imaging | October 16, 2015
October 16, 2015 – The main pumping chamber of the heart ages differently in men and women, according to a new...
RESPECT trial, long-term study results, TCT 2015, PFO closure, recurrent cryptogenic stroke

Image courtesy of GE Healthcare

Feature | Stroke | October 16, 2015
October 16, 2015 — Long-term study results from the RESPECT trial found that closing a patent foramen ovale (PFO) with...
Amaranth Medical Bioresorbable Scaffold, Fortitude stent
News | Stents Bioresorbable | October 16, 2015
October 16, 2015 — Enrollment has successfully concluded in its multi-center, international CE mark clinical trials...
Claret embolic protection, TAVR, cerebral protection

The Claret TAVR embolic protection system as seen in the aortic arch under angiography. The loops contain embolic filters they protect the ostium of vessles leading to the brain.

Feature | Heart Valve Technology | October 16, 2015
October 14, 2015 — Claret Medical, an innovator in cardiovascular cerebral protection, Data presented this week at...
ABSORB III trial, TCT 2015, bioresorbable vascular scaffold, BVS

Abbott's Absorb bioresorbable stent. Image courtesy of Abbott Vascular

Feature | Stents Bioresorbable | October 16, 2015
October 16, 2015 — Results from a clinical trial showed that Abbott's Absorb...
News | Heart Valve Technology | October 15, 2015
October 15, 2015 — Edwards Lifesciences Corp. announced that details on the 13...
SCAI, new bioabsorbable stent technologies, TCT 2015, Absorb, Synergy

Synergy stent image courtesy of Boston Scientific

News | Stents Bioresorbable | October 15, 2015
October 15, 2015 — Two new advances in stent technology announced in recent days further reinforce the effectiveness of...
PARTNER II Trial, TCT 2015, Edwards Lifesciences, Sapien 3 valve, one-year results

Image courtesy of Edwards Lifesciences

Feature | Heart Valve Technology | October 15, 2015
October 15, 2015 — One-year patient outcomes from the PARTNER II trial showed the low rate of 30-day complications with...
Sapien XT, VIV, valve in valve
Technology | Heart Valve Technology | October 15, 2015
October 15, 2015 — U.S. Food and Drug Administration (FDA) has cleared Edwards Lifesciences Sapien XT transcatheter...
BIOSOLVE-II Trial results, TCT 2015, Biotronik Bioresorbable Magnesium Scaffold
News | Stents Bioresorbable | October 15, 2015
October 15, 2015 — Biotronik has announced results from...
Overlay Init